UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549





FORM 10-QSB



QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES AND EXCHANGE ACT OF 1934

---------------------------------------------------------------

For the Quarter Ended January 31, 2005, Commission File Number 0-32887







MYOCASH, INC.

-----------------------------------------------------

(Exact name of Registrant as specified in its charter)





Nevada              02-0718322

---------------------------  ----------------------------------

(State of Incorporation) (I.R.S. Employer Identification Number)





14 Pico Crescent, Thornhill, Ontario L4J 8P4

------------------------------------------------------

(address of principal executive offices) (Zip Code)



Registrant's telephone number, including area code: (905) 731-0189





Not Applicable

-------------------------------------------------------------------

(Former name, address, or fiscal year if changed since last report)



Indicate  by check mark  whether the  registrant  (1) has filed all reports required to be filed by Section 13 or 15(d) of the  Securities  and Exchange Act of 1934  during the  preceding  12 months (or for such  shorter  period that the Registrant was required to file such reports),  and (2) has been subject to such filing requirements for the past 90 days.



Yes         x                No

------------        ------------

The total number of shares outstanding of the issuer's common shares,  par value $ .001 as of the date of this report, follow:



26,250,000











---









PART I - FINANCIAL INFORMATION



Item 1.           Financial Statements





MYOCASH, INC.





INTERIM FINANCIAL STATEMENTS





JANUARY 31, 2005

(UNAUDITED)

















---









MYOCASH, INC.

INTERIM BALANCE SHEET

AS AT January 31, 2005

(UNAUDITED)





January 31,  October 31,

2005         2004

(UNAUDITED)  (AUDITED)



ASSETS



Current Assets

Cash ...............................................$    --           $    --



--------          ------



Total Current Assets ..............................      --                --

--------          ---------



OTHER -  AT COST

Goodwill ..............................................  --                --

Incorporation costs ...................................  --                --

--------          ---------



Total Other Assets                                       --                --

--------          ---------





TOTAL ASSETS                                        $    --            $   --

========       =========





The accompanying notes are an integral part of these financial statements.









---







MYOCASH, INC.

INTERIM BALANCE SHEET

AS AT January 31, 2005

(UNAUDITED)



January 31,  October 31,

2005         2004



LIABILITIES



Accounts payable ...................................$   2,250     $   2,250



LONG-TERM

Due to shareholders                                      --               --

--------          ------



Total Liabilities ..................................    2,250         2.250

--------          ------



STOCKHOLDERS' EQUITY



Preferred stock, authorized 5,000,000 shares par value

$ .001, none outstanding

Common stock, authorized 50,000,000 shares, par value

$ .001 - 6,250,000 issued and outstanding,

(October 31, 2004 - 6,250,000)                   6,250            6,250



Additional paid-in capital ..                            --                --

Deficit, accumulated during the development stage   (8,500)          (7,750)

-------          ---------

(2,250)          (2,250)

-------          ---------



TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY           $   --          $     --

========      =========







The accompanying notes are an integral part of these financial statements.









---







MYOCASH, INC.

INTERIM STATEMENT OF OPERATIONS

(UNAUDITED)





FROM

INCEPTION

(Nov 17, 2000)

THREE MONTHS ENDED       TO

JANUARY 31,        JANUARY 31,

2005     2004            2005

<S>                                      <C>        <C>       <C>

REVENUE .................................$.  --...  $    --    $    --

--------   --------   --------





OPERATING EXPENSES

Professional fees                            --          --       2,250

Amortization expenses                        --          --         --

General and administrative                   --          --       6,250

--------   --------   --------



Total Operating Expenses                     --          --       8,500

--------   --------   --------



NET LOSS FROM OPERATIONS                 $   --     $    --   $  (8,500)

========   ========   ========



Weighted Average Number of

Common Shares Outstanding              6,250,000  6,250,000

=========  =========

Net Loss Per Share                         $ --       $  --

=======     ======



The accompanying notes are an integral part of these financial statements.







---





MYOCASH, INC.

INTERIM STATEMENT OF CASH FLOWS

(UNAUDITED)



FROM

INCEPTION

(Nov 17, 2000)

THREE MONTHS ENDED       TO

JANUARY 31,       JANUARY 31,

2005     2004         2005



Cash Flows From Operating Activities

Net income(loss) for the period ..........$...--...  $    --      $  (8,500)

--------   --------     --------



Adjustments to reconcile net loss to net

cash in operating activities:

Stock issued for services         ..... --          --          5,705

Stock issued for reimbursement

of incorporation costs                 --          --            545

Changes in assets and liabilities

Accounts receivable ....................--......    --           --

Accounts payable ...................... --......    --          2,250

--------   --------      -------

--          --          8,500

--------   --------      -------



Net Cash Provided By(Used in)

Operating Activities                     --          --           --

--------   --------      -------



Cash Flows From Investing Activities

Purchase of goodwill ........................ --          --           --

Incorporation costs ........................  --          --           --

--------   --------      -------



Net Cash Used in Investing Activities ........--          --           --

--------   --------      -------



Cash Flow From Financing Activities

Advances from shareholders ...................--          --           --

Issuance of common stock .....................--......    --           --

--------   --------      -------

--          --           --

--------   --------      -------





Increase(decrease) in Cash ..............     --          --           --



Cash and Cash Equivalents - Beginning of

period                                 --          --           --

--------   --------      -------



Cash and Cash Equivalents - End of

period ........                    $   --     $    --      $    --

========   ========      =======









---





Supplementary Information

Interest paid ..........................$   --     $    --      $    --

========   ========      =======

Taxes paid .............................$   --     $    --      $    --

========   ========      =======





The accompanying notes are an integral part of these financial statements.







---







MYOCASH, INC.

INTERIM STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

From Inception(November 17, 2000) to January 31, 2005

(UNAUDITED)

<

Deficit

Accumulated

Additional    During the

Common Stock      Paid-In     Development

Shares   Amount     Capital       Stage        Totals

---------------------------------------------------------------

Balance - November

17, 2000             --      $   --    $    --    $     --       $    --



Stock issued for

services          4,455,000    4,455        --          --           4,455



Stock issued for

incorporation costs  545,000      545        --          --             545





Net loss for period                                     (5,000)       (5,000)

---------  -------    ---------   --------      --------

BALANCE - October 31,

2001           5,000,000    5,000        --        (5,000)         --



Stock issued for

services          1,250,000    1,250        --          --           1,250



Net loss for

year               --         --          --        (1,250)       (1,250)

----------  -------    ---------   --------      --------

Balance - October

31, 2002         6,250,000    6,250        --        (6,250)         --



Net loss for

year               --         --          --        (1,500)       (1,500)

----------  -------    ---------   --------      --------

Balance - October

31, 2003         6,250,000    6,250        --        (7,750)       (1,500)



Net loss for year      --         --          --          (750)         (750)

----------  -------    ---------   --------      --------

Balance - October

31, 2004         6,250,000    6,250        --        (8,500)       (2,250)



Net loss for period    --         --          --           --           --

----------  -------    ---------   --------      --------



Balance - January

31, 2005         6,250,000 $  6,250   $    --     $  (8,500)    $  (8,500)

==========  =======    ========    ========      ========

The accompanying notes are an integral part of these financial statements.







---





Myocash, Inc.

Notes to Interim Financial Statements

January 31, 2005

(Unaudited)





Note 1 - BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES



Nature of Business

MYOCASH, INC., (the Company) was incorporated on November 17, 2000 under the laws of the State of Nevada.  The Companys primary business operations are to engage in the acquisition of a technology based company.  The Company is searching for a viable entity upon which to merge and/or acquire.  The Company intends on going public in order to raise the funds required in order to fulfill its business objectives.



Development Stage Company

The Company has not earned any revenue from limited principal operations.  Accordingly, the Companys activities have been accounted for as those of a Development Stage Enterprise as set forth in Financial Accounting Standards Board statement No. 7 (SFAS 7).  Among the disclosures required by SFAS 7 are that the Companys financial statements be identified as those of a development stage company, and that the statements of operations, stockholders equity (deficit) and cash flows disclose the activity since the date of the Companys inception.



Recapitalization

On January 17, 2005, the Company completed its objective by executing a reverse acquisition with a home healthcare agency called Family Home Health Services, LLC (the LLC).  The newly combined company, Family Home Health Services, Inc., issued an aggregate of 20,000,000 shares of its common stock to the members of the LLC in exchange for all of the members outstanding membership interests in the LLC.  Also in connection with the transaction, the Companys former sole shareholder transferred an aggregate of 4,050,000 shares of common stock to the former members of the LLC for no additional consideration.  Concurrent with the above transactions, the former members of the LLC became officers of the Company (the former members of the LLC were appointed to the Board of Directors of the Company in November 2004).  For accounting purposes, the transaction has been treated as a recapitalization of the Company with the LLC as the acquirer (i.e., a reverse acquisition).  The Company expects that its shares will begin trading on the OTCBB stock exchange during the third quarter of 2005.









---







Item 2:           Management's Discussion and Analysis or Plan Of Operation



THE  FOLLOWING  DISCUSSION OF THE RESULTS OF OUR  OPERATIONS  AND FINANCIAL CONDITION  SHOULD BE READ IN CONJUNCTION  WITH OUR FINANCIAL  STATEMENTS AND THE NOTES  THERETO  INCLUDED  ELSEWHERE  IN THIS REPORT.  EXCEPT FOR THE HISTORICAL INFORMATION CONTAINED HEREIN, THE DISCUSSION CONTAINED IN THIS REPORT CONTAINS "FORWARD-LOOKING   STATEMENTS THAT INVOLVE RISK AND UNCERTAINTIES.   THESE STATEMENTS MAY BE IDENTIFIED BY THE USE OF FORWARD-LOOKING TERMINOLOGY SUCH AS "BELIEVES,"  "EXPECTS," "MAY," "WILL," "SHOULD" OR "ANTICIPATES" OR THE NEGATIVE THEREOF OR SIMILAR EXPRESSIONS OR BY DISCUSSIONS OF STRATEGY.  THE CAUTIONARY STATEMENTS MADE IN THIS REPORT SHOULD BE READ AS BEING APPLICABLE TO ALL RELATED FORWARD-LOOKING STATEMENTS WHEREVER THEY APPEAR IN THIS REPORT.  OUR ACTUAL RESULTS COULD DIFFER MATERIALLY FROM THOSE DISCUSSED IN THIS REPORT.



Results of Operations



During the period from November 1, 2004 to January 17, 2005, the Company did not generate any revenues.  During that period, Management continued its efforts to raise capital in order to fulfill its business objectives.



On January 17, 2005, the Company completed its objective by Entering into and closing on an Ownership Exchange Agreement by and among the Company, Family Home Health Services, LLC, Kevin R. Ruark and James H. Pilkington (the "Ownership Exchange Agreement"), pursuant to which the Company simultaneously acquired Family Home Health Services, LLC, a Delaware limited liability company that is a provider of home healthcare services in the U.S., primarily in Florida, with a broad service offering in home health services and home medical care.



Under the terms of the Ownership Exchange Agreement, the Company issued 10,000,000 shares of its restricted common stock to each of Messrs. Ruark and Pilkington (an aggregate of 20,000,000 shares) in exchange for all outstanding membership interests of Family Home Health Services, LLC held by them; and Mr. Marvin Winick, the President of the Company, resigned.



As a result of the transaction described above, Family Home Health Services, LLC became a wholly-owned subsidiary of the Company, which is now a holding company with no separate business operations.



The transaction described above with the LLC was reported on our Current report on Form 8-K filed on March 16, 2005, which report was amended by Form 8-K/A filed on March 30, 2005 and further amended by Form 8-K/A filed on or about August 12, 2005. The financial results of the Company for the period from January 17, 2005 through January 31, 2005, the ending period of this report, are contained in the Current Report on Form 8-K/A filed on or about August 12, 2005.









---







Liquidity and Capital Resources



For the period November 1, 2004 through January 17, 2005, the Company had no cash.



ITEM 3.  CONTROLS AND PROCEDURES



(a) Within the 90-day time period prior to filing this report, we conducted as  an  evaluation  of  the  effectiveness  of  our  "disclosure  controls  and procedures,"  as that phrase is defined in Rules  13a-14(c) and 15d-14(c)  under the  Securities  Exchange Act of 1934.  The evaluation was carried out under the supervision and with the participation of management, including our President.



Based  on and  as of the  date  of  that  evaluation,  our  President  have concluded  that our  disclosure  controls and procedures are effective in timely alerting him to material  information required to be disclosed in the reports we file with or submit to the Securities and Exchange  Commission ("SEC") under the Securities  Exchange Act of 1934, and in ensuring that the information  required to be disclosed in those filings is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms.



Notwithstanding  the  foregoing,  there  can  be  no  assurance  that the Company's disclosure controls and procedures will detect or uncover all failures of  persons  within the  Company  to  disclose  material  information  otherwise required to be set forth in the Company's  periodic reports.  There are inherent limitations  to the  effectiveness  of any  system of  disclosure  controls  and procedures,  including the possibility of human error and the  circumvention  or overriding  of  the  controls  and  procedures.   Accordingly,   even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.



(b)  Subsequent to the date of the evaluation, there were no  significant changes in internal controls or in other factors that could significantly affect the internal  controls,  including any  corrective  actions taken with regard to significant deficiencies and material weaknesses.





PART II - OTHER INFORMATION



Item 1:           Legal Proceedings



There are no legal proceedings applicable.



Item 2:           Changes in Securities and Use of Proceeds



Not Applicable



Item 3:           Defaults upon Senior Securities



Not Applicable.







---







Item 4:           Submission of Matters to a Vote of Security Holders



Not Applicable



Item 5:           OTHER INFORMATION



None



Item 6:           Exhibits





Exhibit 31 & 32   Certifications







---











SIGNATURES



Pursuant to the requirements  of the Securities  Exchange Act of 1934, the Registrant has duly caused this report to be signed by the undersigned thereunto duly authorized.



MYOCASH, INC.



BY:      /s/   Marvin Winick

-------------------------------

Marvin Winick, President



Dated:   August 12, 2005









---







EXHIBIT INDEX





31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.



31.2

Certification Pursuant Section 906 of the Sarbanes-Oxley Act of 2002.









---





EXHIBITS



Exhibit 31.1



CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)









I, Marvin N. Winick, certify that;





1. I have reviewed this quarterly report on Form 10-QSB of Myocash, Inc.



2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact  necessary to make the statements made, in light of the  circumstances  under which such statements were made, not  misleading  with respect to the period covered by this quarterly report;



3. Based on my knowledge,  the financial  statements,  and other  financial information  included in this quarterly  report,  fairly present in all material respects the financial  condition,  results of operations  and cash flows of the registration as of, and for, the periods presented in this quarterly report;



4. I am responsible for  establishing and maintaining  disclosure  controls and  procedures  (as  defined in Exchange  Act Rules  13a-14 and 15d-14) for the registrant and have:



a) designed such disclosure  controls and procedure to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others  within those  entities,  particularly  during the period in which this quarterly report is being prepared;



b) evaluated the effectiveness of the registrant's  disclosure controls and procedures  as of a date  within  90  days  prior  to the  filing  date  of this quarterly report (the "Evaluation Date"); and



c)  presented  in  this  quarterly   report  our   conclusions   about  the effectiveness of the disclosure  controls and procedures based on our evaluation as of the Evaluation Date;



5.  I  have  disclosed,  based  on  our  most  recent  evaluation,  to  the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):



a) all  significant  deficiencies  in the design or  operation  of internal controls  which  could  adversely  affect  the  registrant's  ability to record, process,  summarize  and  report  financial  data  and have  identified  for the registrant's auditors any material weaknesses in internal controls; and









---





b) any fraud,  whether or not material,  that involves  management or other employees who have a significant role in the registrant's internal controls; and



6. I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal  controls  subsequent  to the  date  of  our  most  recent  evaluation, including any  corrective  actions with regard to significant  deficiencies  and material weaknesses.











/s/ Marvin Winick

---------------------------------------------

Marvin Winick

President











August 12, 2005









---

















EXHIBIT 32.1



CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)







In  connection  with  the  Quarterly  Report  of  Myocash,  Inc.,  a Nevada corporation (the  "Company"),  on Form 10-QSB for the quarter ending January 31, 2005 as filed with the Securities and Exchange  Commission  (the "Report"),  I, Marvin N. Winick President & CEO, of the Company,  certify, pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002 (18  U.S.C. Section  1350),  that to my knowledge:



1. The Report fully  complies  with the  requirements  of section  13(a) or 15(d) of the Securities Exchange Act of 1934; and



2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.







/s/ Marvin Winick

-------------------------------------------

Marvin N. Winick

President & CEO





August 12, 2005